vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and Verisign (VRSN). Click either name above to swap in a different company.
Verisign is the larger business by last-quarter revenue ($425.3M vs $359.9M, roughly 1.2× AdvanSix Inc.). Verisign runs the higher net margin — 48.5% vs -0.8%, a 49.3% gap on every dollar of revenue. On growth, AdvanSix Inc. posted the faster year-over-year revenue change (9.4% vs 7.6%). Verisign produced more free cash flow last quarter ($285.1M vs $36.1M). Over the past eight quarters, Verisign's revenue compounded faster (5.2% CAGR vs 3.4%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
Verisign, Inc. is an American company based in Reston, Virginia, that operates a diverse array of network infrastructure, including two of the Internet's thirteen root nameservers, the authoritative registry for the .com, .net, and .name generic top-level domains and the .cc country-code top-level domains, and the back-end systems for the .jobs and .edu sponsored top-level domains.
ASIX vs VRSN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $425.3M |
| Net Profit | $-2.8M | $206.2M |
| Gross Margin | 7.6% | 88.5% |
| Operating Margin | -0.7% | 67.0% |
| Net Margin | -0.8% | 48.5% |
| Revenue YoY | 9.4% | 7.6% |
| Net Profit YoY | -892.9% | 7.7% |
| EPS (diluted) | $-0.11 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $359.9M | $425.3M | ||
| Q3 25 | $374.5M | $419.1M | ||
| Q2 25 | $410.0M | $409.9M | ||
| Q1 25 | $377.8M | $402.3M | ||
| Q4 24 | $329.1M | $395.4M | ||
| Q3 24 | $398.2M | $390.6M | ||
| Q2 24 | $453.5M | $387.1M | ||
| Q1 24 | $336.8M | $384.3M |
| Q4 25 | $-2.8M | $206.2M | ||
| Q3 25 | $-2.6M | $212.8M | ||
| Q2 25 | $31.4M | $207.4M | ||
| Q1 25 | $23.3M | $199.3M | ||
| Q4 24 | $352.0K | $191.5M | ||
| Q3 24 | $22.3M | $201.3M | ||
| Q2 24 | $38.9M | $198.8M | ||
| Q1 24 | $-17.4M | $194.1M |
| Q4 25 | 7.6% | 88.5% | ||
| Q3 25 | 6.8% | 88.4% | ||
| Q2 25 | 14.3% | 88.0% | ||
| Q1 25 | 14.2% | 87.7% | ||
| Q4 24 | 3.4% | 87.8% | ||
| Q3 24 | 14.4% | 88.0% | ||
| Q2 24 | 17.9% | 87.8% | ||
| Q1 24 | 0.9% | 87.2% |
| Q4 25 | -0.7% | 67.0% | ||
| Q3 25 | -0.9% | 67.8% | ||
| Q2 25 | 7.7% | 68.5% | ||
| Q1 25 | 7.7% | 67.4% | ||
| Q4 24 | -3.9% | 66.7% | ||
| Q3 24 | 7.5% | 68.9% | ||
| Q2 24 | 11.5% | 68.8% | ||
| Q1 24 | -7.0% | 67.4% |
| Q4 25 | -0.8% | 48.5% | ||
| Q3 25 | -0.7% | 50.8% | ||
| Q2 25 | 7.7% | 50.6% | ||
| Q1 25 | 6.2% | 49.5% | ||
| Q4 24 | 0.1% | 48.4% | ||
| Q3 24 | 5.6% | 51.5% | ||
| Q2 24 | 8.6% | 51.4% | ||
| Q1 24 | -5.2% | 50.5% |
| Q4 25 | $-0.11 | — | ||
| Q3 25 | $-0.10 | — | ||
| Q2 25 | $1.15 | — | ||
| Q1 25 | $0.86 | — | ||
| Q4 24 | $0.02 | — | ||
| Q3 24 | $0.82 | — | ||
| Q2 24 | $1.43 | — | ||
| Q1 24 | $-0.65 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $580.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $815.2M | $-2.2B |
| Total Assets | $1.7B | $1.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | $580.5M | ||
| Q3 25 | $23.7M | $617.7M | ||
| Q2 25 | $18.4M | $593.8M | ||
| Q1 25 | $8.3M | $648.5M | ||
| Q4 24 | $19.6M | $599.9M | ||
| Q3 24 | $17.3M | $644.9M | ||
| Q2 24 | $12.1M | $689.9M | ||
| Q1 24 | $20.6M | $924.7M |
| Q4 25 | $815.2M | $-2.2B | ||
| Q3 25 | $818.2M | $-2.1B | ||
| Q2 25 | $823.7M | $-2.0B | ||
| Q1 25 | $794.4M | $-2.0B | ||
| Q4 24 | $774.6M | $-2.0B | ||
| Q3 24 | $766.4M | $-1.9B | ||
| Q2 24 | $746.6M | $-1.8B | ||
| Q1 24 | $713.2M | $-1.6B |
| Q4 25 | $1.7B | $1.3B | ||
| Q3 25 | $1.7B | $1.4B | ||
| Q2 25 | $1.6B | $1.4B | ||
| Q1 25 | $1.6B | $1.4B | ||
| Q4 24 | $1.6B | $1.4B | ||
| Q3 24 | $1.5B | $1.5B | ||
| Q2 24 | $1.5B | $1.5B | ||
| Q1 24 | $1.5B | $1.7B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $289.6M |
| Free Cash FlowOCF − Capex | $36.1M | $285.1M |
| FCF MarginFCF / Revenue | 10.0% | 67.0% |
| Capex IntensityCapex / Revenue | 7.7% | 1.1% |
| Cash ConversionOCF / Net Profit | — | 1.40× |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $1.1B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $289.6M | ||
| Q3 25 | $26.6M | $307.7M | ||
| Q2 25 | $21.1M | $202.5M | ||
| Q1 25 | $11.4M | $291.3M | ||
| Q4 24 | $64.2M | $231.5M | ||
| Q3 24 | $57.3M | $253.4M | ||
| Q2 24 | $50.2M | $160.4M | ||
| Q1 24 | $-36.2M | $257.3M |
| Q4 25 | $36.1M | $285.1M | ||
| Q3 25 | $66.0K | $303.0M | ||
| Q2 25 | $-7.2M | $194.7M | ||
| Q1 25 | $-22.6M | $285.5M | ||
| Q4 24 | $29.8M | $222.0M | ||
| Q3 24 | $26.8M | $247.8M | ||
| Q2 24 | $16.7M | $151.2M | ||
| Q1 24 | $-71.6M | $253.5M |
| Q4 25 | 10.0% | 67.0% | ||
| Q3 25 | 0.0% | 72.3% | ||
| Q2 25 | -1.7% | 47.5% | ||
| Q1 25 | -6.0% | 71.0% | ||
| Q4 24 | 9.1% | 56.1% | ||
| Q3 24 | 6.7% | 63.4% | ||
| Q2 24 | 3.7% | 39.1% | ||
| Q1 24 | -21.3% | 66.0% |
| Q4 25 | 7.7% | 1.1% | ||
| Q3 25 | 7.1% | 1.1% | ||
| Q2 25 | 6.9% | 1.9% | ||
| Q1 25 | 9.0% | 1.4% | ||
| Q4 24 | 10.4% | 2.4% | ||
| Q3 24 | 7.7% | 1.4% | ||
| Q2 24 | 7.4% | 2.4% | ||
| Q1 24 | 10.5% | 1.0% |
| Q4 25 | — | 1.40× | ||
| Q3 25 | — | 1.45× | ||
| Q2 25 | 0.67× | 0.98× | ||
| Q1 25 | 0.49× | 1.46× | ||
| Q4 24 | 182.29× | 1.21× | ||
| Q3 24 | 2.57× | 1.26× | ||
| Q2 24 | 1.29× | 0.81× | ||
| Q1 24 | — | 1.33× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
VRSN
Segment breakdown not available.
